FindTrial
Sign In

Study on accurate diagnosis and treatment of differentiated thyroid carcinoma with pulmonary metastasis based on artificial intelligence and multiomics analysis

Study on accurate diagnosis and treatment of differentiated thyroid carcinoma with pulmonary metastasis based on artificial intelligence and multiomics analysis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037168
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Gold Standard:Pathologic diagnosis.
Index test:A&#32
predictive&#32
model&#32
for&#32
iodine&#32
uptake&#32
in&#32
lung&#32
metastasis&#32
of&#32
differentiated&#32
thyroid&#32
carcinoma.

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Confirmed lung metastasis of DTC; 2. Patients treated with iodine-131; 3. Surgical and pathological data available; 4. Preformed chest CT examination before iodine-131 treatment; 5. Whole-body iodine scanning results after iodine-131 treatment available; 6. TSH, Tg, TgAb values available before iodine-131 treatment;7.Surgical pathology section available.

Exclusion criteria

Exclusion criteria: With a history of other malignant tumors.

Design outcomes

Primary

MeasureTime frame
iodine-131 treatment outcome;SEN, SPE, ACC, AUC of ROC, PPV, NPV;—

Countries

China

Contacts

Public ContactQuanyong Luo

Shanghai Sixth People's Hospital

luoqy@sjtu.edu.cn+86 18930177672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026